Burjeel Cancer Institute in Abu Dhabi has introduced targeted radiopharmaceutical treatment for patients with certain metastatic tumours.

The details

Burjeel Cancer Institute has introduced targeted radiopharmaceutical treatment for patients with certain types of metastatic tumours. The treatment uses radioactive therapies directed at receptors expressed on tumour cells, aiming to deliver treatment more precisely while limiting exposure to surrounding healthy tissue.

The programme is supported by the Department of Health – Abu Dhabi and forms part of the emirate’s expansion of precision oncology and advanced molecular medicine.

Eligibility depends on tumour type, clinical assessment and treatment protocols. The development adds a specialist option to Abu Dhabi’s cancer-care landscape, but it is not a general treatment for all cancers and should not be described as a cure.